-Used in patients with metastatic colorectal cancer who have had a prior treatment with fluoropyrimidine, oxaliplatin, irinotecan-based chemotherapy; anti-VEGF therapy; or if RAS wild-type, an anti-EGFR therapy. Here, VEGFA is linked to metastatic colorectal cancer.